Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

Adam C. Berger, Jeffrey Farma, Walter J. Scott, Gary Freedman, Louis Weiner, Jonathan D. Cheng, Hao Wang, Melvyn Goldberg

Research output: Contribution to journalArticle

Abstract

Purpose: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. Patients and Methods: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. Results: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or 1 had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P <.0001 and P

Original languageEnglish (US)
Pages (from-to)4330-4337
Number of pages8
JournalJournal of Clinical Oncology
Volume23
Issue number19
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Chemoradiotherapy
Carcinoma
Survival
Esophagectomy
Disease-Free Survival
Survival Rate
Esophageal Neoplasms
Proportional Hazards Models
Multivariate Analysis
Recurrence
Mortality
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Berger, A. C., Farma, J., Scott, W. J., Freedman, G., Weiner, L., Cheng, J. D., ... Goldberg, M. (2005). Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. Journal of Clinical Oncology, 23(19), 4330-4337. https://doi.org/10.1200/JCO.2005.05.017

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. / Berger, Adam C.; Farma, Jeffrey; Scott, Walter J.; Freedman, Gary; Weiner, Louis; Cheng, Jonathan D.; Wang, Hao; Goldberg, Melvyn.

In: Journal of Clinical Oncology, Vol. 23, No. 19, 2005, p. 4330-4337.

Research output: Contribution to journalArticle

Berger, Adam C. ; Farma, Jeffrey ; Scott, Walter J. ; Freedman, Gary ; Weiner, Louis ; Cheng, Jonathan D. ; Wang, Hao ; Goldberg, Melvyn. / Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. In: Journal of Clinical Oncology. 2005 ; Vol. 23, No. 19. pp. 4330-4337.
@article{c73c689fbad7492b82bc0d539e750e7a,
title = "Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival",
abstract = "Purpose: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. Patients and Methods: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. Results: Of 171 patients with invasive cancer, 131 (77{\%}) underwent preoperative CRT. The average age was 60 years, and most patients were male (85{\%}). Operations performed included Ivor-Lewis (60{\%}), transhiatal (8{\%}), three-hole (23{\%}), or left thoracoabdominal (8{\%}) esophagectomy. Perioperative mortality rate was 5{\%}. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26{\%}. Induction CRT was associated with a 33{\%} 5-year survival rate compared with 11{\%} for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or 1 had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P <.0001 and P",
author = "Berger, {Adam C.} and Jeffrey Farma and Scott, {Walter J.} and Gary Freedman and Louis Weiner and Cheng, {Jonathan D.} and Hao Wang and Melvyn Goldberg",
year = "2005",
doi = "10.1200/JCO.2005.05.017",
language = "English (US)",
volume = "23",
pages = "4330--4337",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "19",

}

TY - JOUR

T1 - Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

AU - Berger, Adam C.

AU - Farma, Jeffrey

AU - Scott, Walter J.

AU - Freedman, Gary

AU - Weiner, Louis

AU - Cheng, Jonathan D.

AU - Wang, Hao

AU - Goldberg, Melvyn

PY - 2005

Y1 - 2005

N2 - Purpose: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. Patients and Methods: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. Results: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or 1 had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P <.0001 and P

AB - Purpose: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. Patients and Methods: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. Results: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or 1 had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P <.0001 and P

UR - http://www.scopus.com/inward/record.url?scp=22344446070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22344446070&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.05.017

DO - 10.1200/JCO.2005.05.017

M3 - Article

C2 - 15781882

AN - SCOPUS:22344446070

VL - 23

SP - 4330

EP - 4337

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -